Shares of Haleon PLC HLN inched down 0.91% to £3.72 Friday, on what proved to be an all-around grim trading session for the ...

Shares of Haleon PLC HLN inched up 0.97% to £3.75 Thursday, on what proved to be an all-around favorable trading session for ...

Haleon's global business lead for the Pain Portfolio & Systemics shares key consumer health trends reshaping the healthcare ...

On Jan 15, Pfizer Inc. ( PFE, Financial) announced to sale of about 700 million ordinary shares of Haleon plc through a ...

The sale decreases Pfizer’s shareholding in the consumer-healthcare business to 7.3% of its issued share capital, down from ...

(Bloomberg) -- Pfizer Inc. sold about 700 million shares in Haleon Plc, further paring its stake in the maker of Sensodyne ...

Haleon, a global leader in consumer health, has taken a revolutionizing step for pain management by launching the Haleon Pain ...

AdvisorNet Financial Inc reduced its stake in shares of Haleon plc (NYSE:HLN – Free Report) by 34.0% in the fourth quarter, ...

In a report released today, David Hayes from Jefferies maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target of ...

Marcum Wealth LLC raised its holdings in shares of Haleon plc (NYSE:HLN – Free Report) by 19.7% in the fourth quarter, ...

LAHORE: Haleon, multinational company is establishing a Pain Management Institute in Lahore to carry out research ...